Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells
Jan Daebritz, Louise M Judd, Heather V Chalinor, Trevelyan R Menheniott, Andrew S Giraud
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2016
Awarded by German Research Foundation (DFG)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by United European Gastroenterology
Awarded by Worldwide Cancer Research
This work was supported by a research fellowship (J.D.) from the German Research Foundation (DFG DA1161/5-1) and a career development award (J.D.) from the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). This work was also supported by a project grant (#509165), career development awards (L.M.J., T.R.M.) and a senior research fellowship (A.S.G.) from the National Health and Medical Research Council (NHMRC) of Australia. The authors thank the United European Gastroenterology for the National Scholar Award 2013 and also for a travel grant (#UEG13-ABS-1586), which supported the presentation of the research at the 21st United European Gastroenterology Week 2013 in Berlin, Germany.